---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-029384"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2024-07-29T23:59:59+00:00"
generated_at: "2026-05-31T15:47:06.789915+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics raises $3M from Dr. Ronald Rigor; launches Nova Cell subsidiary with $2M investment

## Summary
- Dr. Ronald Rigor invests $1M in Calidi via 698,812 shares at $1.431 and warrants for 600,000 shares at $1.90.
- Dr. Rigor invests $2M in Nova Cell subsidiary for 25% fully-diluted equity; IP assigned to Nova Cell.
- Dr. Rigor appointed to Scientific and Medical Advisory Board; receives 5,000 stock options.
- Exclusive license for Philippines for AAA stem cells and CLD-201; initial revenue expected 2025.
- Nova Cell to focus on regenerative medicine, cosmetics, orthopedics; Calidi retains oncology focus.

## SEC filing metadata
- accession: 0001493152-24-029384
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2024-07-29T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315224029384/0001493152-24-029384-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315224029384/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-029384
- JSON: https://secwatch.observer/filing/0001493152-24-029384.json
- Plain text: https://secwatch.observer/filing/0001493152-24-029384.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.